GGrantIndex
← Search

Leadership, Planning and Evaluation

$5,113,205P30FY2024CANIH

Mayo Clinic Rochester, Rochester MN

Investigators

Linked publications, trials & patents

Trial NCT06508463Trial NCT06387979Trial NCT06381154Trial NCT06353191Trial NCT06315595Trial NCT06271291Trial NCT06238648Trial NCT06207188Trial NCT06160206Trial NCT06115772Trial NCT06078709Trial NCT06075524Trial NCT06073951Trial NCT06058663Trial NCT05917145Trial NCT05910801Trial NCT05720624Trial NCT05717153Trial NCT05704283Trial NCT05703399Trial NCT05674123Trial NCT05653661Trial NCT05640765Trial NCT05612100Trial NCT05591092Trial NCT05584449Trial NCT05575440Trial NCT05560009Trial NCT05557877Trial NCT05556525Trial NCT05549661Trial NCT05547386Trial NCT05547347Trial NCT05541016Trial NCT05530759Trial NCT05526417Trial NCT05523154Trial NCT05518903Trial NCT05512767Trial NCT05507879Trial NCT05507541Trial NCT05497804Trial NCT05465954Trial NCT05465941Trial NCT05447923Trial NCT05447910Trial NCT05443971Trial NCT05438563Trial NCT05417867Trial NCT05416983Trial NCT05412953Trial NCT05411523Trial NCT05411497Trial NCT05410977Trial NCT05407038Trial NCT05407025Trial NCT05403580Trial NCT05399004Trial NCT05393713Trial NCT05392946Trial NCT05388877Trial NCT05388851Trial NCT05388058Trial NCT05388006Trial NCT05356897Trial NCT05294367Trial NCT05288062Trial NCT05269381Trial NCT05246670Trial NCT05232851Trial NCT05224271Trial NCT05222620Trial NCT05212428Trial NCT05199285Trial NCT05194293Trial NCT05176223Trial NCT05168163Trial NCT05130060Trial NCT05112627Trial NCT05112614Trial NCT05111314Trial NCT05077735Trial NCT05075980Trial NCT05053100Trial NCT05045066Trial NCT05033288Trial NCT05030298Trial NCT05018208Trial NCT05005182Trial NCT04999826Trial NCT04975516Trial NCT04967196Trial NCT04926948Trial NCT04925817Trial NCT04917744Trial NCT04906369Trial NCT04897009Trial NCT04895735Trial NCT04892277Trial NCT04892264

Abstract

LEADERSHIP, PLANNING AND EVALUATION PROJECT SUMMARY The Mayo Clinic Cancer Center (MCCC) has a robust planning and evaluation process in place across all of its sites. Dr. Diasio as Director leads a strong senior leadership team with each team member having a well- defined role and responsibilities. These include: Dr. Robert Smallridge as Deputy Director for Mayo Clinic in Florida (MCF), Dr. Aleksandar Sekulic as Deputy Director for Mayo Clinic in Arizona (MCA), Dr. Daniel Billadeau as Deputy Director for Basic Science, Dr. Steven Alberts as Deputy Director for Clinical Research, Dr. Gloria Petersen as Deputy Director for Population Sciences, Ms. Jane Welter as Deputy Director for Administration, Dr. Thomas Witzig as Associate Director for Translational Research, Dr. Aminah Jatoi as Associate Director for Research Education, and Dr. Carmen Radecki-Breitkopf as Associate Director for Cancer Disparities and Community Outreach. Members of the senior leadership team meet twice monthly; once as the senior most leadership committee made up of Director and Deputy Directors, the MCCC Executive Committee, and once as a larger group with the Associate Directors, the MCCC Research Committee. The MCCC Research Committee receives input from the Internal Scientific Advisory Committee and the Clinical Research Committee. Dr. Diasio and the Center receive advisory input internally from the Mayo Clinic Research Committee, directed by the Executive Dean for Research and externally from the External Advisory Committee made up of directors and senior leaders from other centers who provide expertise in the various program areas. The center also benefits from expertise provided by a Community Advisory Board made up of patients, family members of patients, and advocates in various cancer areas. Since the last competitive renewal, MCCC has conducted strategic planning that has resulted in a number of new research directions that have been undertaken leading to a number of new directions and accomplishments.

View original record on NIH RePORTER →